Jay Venkatesan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jay Venkatesan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jay Venkatesan. Jay Venkatesan is Director in Targanta Therapeutics Corp. ($TARG) and Director in Lion Biotechnologies, Inc. ($LBIO) and See Remarks in Angion Biomedica Corp. ($ANG) and Director in ALPINE IMMUNE SCIENCES, INC. ($ALPN) and President in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Max-1 Acquisition Corp ($XCUR).
Latest Insider Trading Transactions of Jay Venkatesan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ANG, XCUR, IOVA, TARG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2021 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Option Exercise | M | 3.62 | 7,650 | 27,718 | 0 | |
| Apr 23 2021 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Option Exercise | M | 4.09 | 7,650 | 31,289 | 0 | |
| Apr 23 2021 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Buy | M | 3.62 | 7,650 | 27,718 | 218,063 | 210.4 K to 218.1 K (+3.64 %) |
| Apr 23 2021 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Buy | M | 4.09 | 7,650 | 31,289 | 210,413 | 202.8 K to 210.4 K (+3.77 %) |
| Feb 11 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Option Exercise | X | 6.43 | 237,152 | 1,524,887 | 0 | |
| Feb 11 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Option Exercise | C | 0.00 | 1,804 | 0 | 0 | |
| Feb 11 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Buy | C | 11.57 | 262 | 3,031 | 1,280,348 | 1.3 M to 1.3 M (+0.02 %) |
| Feb 11 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Sell | S | 16.00 | 159,177 | 2,546,832 | 1,208,086 | 1.4 M to 1.2 M (-11.64 %) |
| Feb 11 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Buy | X | 6.43 | 237,152 | 1,524,887 | 1,439,263 | 1.2 M to 1.4 M (+19.73 %) |
| Feb 11 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Buy | C | 0.00 | 165,094 | 0 | 1,202,111 | 1 M to 1.2 M (+15.92 %) |
| Feb 11 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Payment of Exercise | F | 16.00 | 31,966 | 511,456 | 1,037,017 | 1.1 M to 1 M (-2.99 %) |
| Feb 08 2021 | ANG | Angion Biomedica C ... | Venkatesan Jay | See Remarks | Option Exercise | A | 16.00 | 178,920 | 2,862,720 | 178,920 | |
| Dec 22 2020 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Buy | J | 0.00 | 181,024 | 0 | 202,763 | 21.7 K to 202.8 K (+832.72 %) |
| Dec 22 2020 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Sell | J | 0.00 | 993,801 | 0 | 3,000,980 | 4 M to 3 M (-24.88 %) |
| Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | M | 1.03 | 12,930 | 13,318 | 0 | |
| Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | M | 0.65 | 9,310 | 6,052 | 0 | |
| Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Buy | M | 1.03 | 12,930 | 13,318 | 324,473 | 311.5 K to 324.5 K (+4.15 %) |
| Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Buy | M | 0.65 | 9,310 | 6,052 | 311,544 | 302.2 K to 311.5 K (+3.08 %) |
| Jun 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | A | 2.79 | 21,693 | 60,523 | 21,693 | |
| Jan 06 2020 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Option Exercise | A | 3.62 | 7,650 | 27,718 | 7,650 | |
| Aug 06 2019 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Buy | P | 2.00 | 250,000 | 500,000 | 302,234 | 52.2 K to 302.2 K (+478.62 %) |
| Jun 14 2019 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | A | 2.78 | 21,693 | 60,307 | 21,693 | |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Option Exercise | P | 12.74 | 74,441 | 948,378 | 74,441 | |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Option Exercise | P | 12.74 | 74,441 | 948,378 | 74,441 | |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Buy | P | 5.37 | 190,875 | 1,024,999 | 3,994,781 | 3.8 M to 4 M (+5.02 %) |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Buy | P | 5.37 | 190,875 | 1,024,999 | 3,994,781 | 3.8 M to 4 M (+5.02 %) |
| Jan 04 2019 | ALPN | ALPINE IMMUNE SCIE ... | Venkatesan Jay | Director | Option Exercise | A | 4.09 | 7,650 | 31,289 | 7,650 | |
| Jun 21 2018 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | A | 5.82 | 21,693 | 126,253 | 21,693 | |
| Jan 04 2018 | NVLS | ALPINE IMMUNE SCIE ... | Venkatesan Jay | President | Option Exercise | A | 11.31 | 25,000 | 282,750 | 25,000 | |
| Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Option Exercise | A | 4.21 | 24,824 | 104,509 | 24,824 | |
| Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Option Exercise | A | 1.03 | 12,929 | 13,317 | 12,929 | |
| Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Option Exercise | A | 0.65 | 9,309 | 6,051 | 9,309 | |
| Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Buy | P | 3.00 | 66,666 | 199,998 | 156,858 | 90.2 K to 156.9 K (+73.92 %) |
| Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Grant | A | 0.00 | 52,234 | 0 | 52,234 | 0 to 52.2 K |
| Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Buy | J | 0.00 | 90,192 | 0 | 90,192 | 0 to 90.2 K |
| Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Buy | J | 0.00 | 190,957 | 0 | 190,957 | 0 to 191 K |
| Jul 26 2017 | NVLS | ALPINE IMMUNE SCIE ... | Venkatesan Jay | President | Option Exercise | A | 0.45 | 90,063 | 40,528 | 90,063 | |
| Jul 26 2017 | NVLS | ALPINE IMMUNE SCIE ... | Venkatesan Jay | President | Buy | J | 0.00 | 3,803,906 | 0 | 3,803,906 | 0 to 3.8 M |
| Jul 26 2017 | NVLS | ALPINE IMMUNE SCIE ... | Venkatesan Jay | President | Grant | A | 0.00 | 21,739 | 0 | 21,739 | 0 to 21.7 K |
| Jul 26 2017 | NVLS | ALPINE IMMUNE SCIE ... | Venkatesan Jay | President | Buy | J | 0.00 | 18,633 | 0 | 18,633 | 0 to 18.6 K |
| Jul 26 2017 | NVLS | ALPINE IMMUNE SCIE ... | Venkatesan Jay | President | Buy | J | 0.00 | 18,633 | 0 | 18,633 | 0 to 18.6 K |
| Jun 05 2017 | LBIO | Lion Biotechnologi ... | Venkatesan Jay | Director | Option Exercise | A | 5.45 | 35,000 | 190,750 | 35,000 | |
| Aug 18 2016 | LBIO | Lion Biotechnologi ... | Venkatesan Jay | Director | Option Exercise | A | 9.10 | 35,000 | 318,500 | 35,000 | |
| Jun 16 2015 | LBIO | Lion Biotechnologi ... | Venkatesan Jay | Director | Option Exercise | A | 11.05 | 35,000 | 386,750 | 35,000 | |
| Jun 03 2008 | TARG | Targanta Therapeut ... | Venkatesan Jay | Director | Option Exercise | A | 7.71 | 10,000 | 77,100 | 10,000 | |
| Oct 17 2007 | TARG | Targanta Therapeut ... | Venkatesan Jay | Director | Option Exercise | A | 10.00 | 25,000 | 250,000 | 25,000 | |
| Oct 17 2007 | TARG | Targanta Therapeut ... | Venkatesan Jay | Director | Option Exercise | C | 10.45 | 103,695 | 1,083,613 | 103,695 | |
| Oct 17 2007 | TARG | Targanta Therapeut ... | Venkatesan Jay | Director | Option Exercise | C | 0.00 | 1,674,390 | 0 | 0 | |
| Oct 17 2007 | TARG | Targanta Therapeut ... | Venkatesan Jay | Director | Option Exercise | C | 13.06 | 82,956 | 1,083,405 | 0 | |
| Oct 17 2007 | TARG | Targanta Therapeut ... | Venkatesan Jay | Director | Buy | P | 10.00 | 575,000 | 5,750,000 | 2,667,987 | 2.1 M to 2.7 M (+27.47 %) |
| Oct 17 2007 | TARG | Targanta Therapeut ... | Venkatesan Jay | Director | Buy | C | 0.00 | 2,092,987 | 0 | 2,092,987 | 0 to 2.1 M |
Page: 1